Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

electroCore, Inc. (ECOR)

4.55   -0.14 (-2.99%) 06-06 15:59
Open: 4.65 Pre. Close: 4.69
High: 4.7115 Low: 4.53
Volume: 14,703 Market Cap: 22(M)

Technical analysis

as of: 2023-06-06 4:27:23 PM
Short-term rate:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Mid-term rate:       
Target: Six months: 6.85     One year: 7.83
Support: Support1: 4.5    Support2: 3.74
Resistance: Resistance1: 5.86    Resistance2: 6.71
Pivot: 5.34
Moving Average: MA(5): 4.69     MA(20): 5.56
MA(100): 5.14     MA(250): 6
MACD: MACD(12,26): -0.4     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 3.8     %D(3): 4.4
RSI: RSI(14): 31.6
52-week: High: 10.5  Low: 2.92
Average Vol(K): 3-Month: 23 (K)  10-Days: 16 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ECOR ] has closed above bottom band by 15.6%. Bollinger Bands are 17.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.72 - 4.75 4.75 - 4.78
Low: 4.45 - 4.49 4.49 - 4.53
Close: 4.49 - 4.55 4.55 - 4.61

Company Description

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Headline News

Fri, 26 May 2023
electroCore (ECOR) Announces Departure of JP Errico from Board -

Tue, 23 May 2023
ElectroCore to Participate at 13th Annual LD Micro Invitational XIII -

Thu, 04 May 2023
HC Wainwright & Co. Maintains ElectroCore (ECOR) Buy ... - Nasdaq

Wed, 19 Apr 2023
electroCore to Announce First Quarter Financial Results on Wednesday, May 3 - Yahoo Finance

Wed, 19 Apr 2023
CG Capital Reiterates ElectroCore (ECOR) Outperform ... - Nasdaq

Wed, 12 Apr 2023
electroCore Expands Intellectual Patent Portfolio for nVNS Technology - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 5 (M)
Shares Float 4 (M)
% Held by Insiders 17.4 (%)
% Held by Institutions 17.2 (%)
Shares Short 85 (K)
Shares Short P.Month 83 (K)

Stock Financials

EPS -4.5
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.5
Profit Margin (%) -237
Operating Margin (%) -245.5
Return on Assets (ttm) -52.4
Return on Equity (ttm) -102.9
Qtrly Rev. Growth 46.4
Gross Profit (p.s.) 1.51
Sales Per Share 1.99
EBITDA (p.s.) -4.78
Qtrly Earnings Growth 0
Operating Cash Flow -18 (M)
Levered Free Cash Flow -11 (M)

Stock Valuations

PE Ratio -1.02
PEG Ratio 0
Price to Book value 1.82
Price to Sales 2.28
Price to Cash Flow -1.22

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.